Periprocedural	B:C3839342
myocardial	I:C3839342
infarction	I:C3839342
during	O
percutaneous	O
coronary	I:C1532338
intervention	I:C1532338
in	O
an	O
academic	O
tertiary	I:C0587437
centre	I:C0587437
in	O
Johannesburg	O
.	O

Periprocedural	O
myocardial	I:C3839342
infarction	I:C3839342
during	O
percutaneous	B:C1532338
coronary	I:C1532338
intervention	I:C1532338
in	O
an	O
academic	O
tertiary	I:C0587437
centre	I:C0587437
in	O
Johannesburg	O
.	O

Periprocedural	O
myocardial	I:C3839342
infarction	I:C3839342
during	O
percutaneous	O
coronary	I:C1532338
intervention	I:C1532338
in	O
an	O
academic	B:C0587437
tertiary	I:C0587437
centre	I:C0587437
in	O
Johannesburg	O
.	O

Percutaneous	B:C1532338
coronary	I:C1532338
intervention	I:C1532338
(	O
Percutaneous	O
coronary	I:C1532338
intervention	I:C1532338
)	O
is	O
effective	O
therapy	O
for	O
significant	O
atherosclerotic	O
coronary	I:C0010054
artery	I:C0010054
disease	I:C0010054
.	O

Percutaneous	O
coronary	I:C1532338
intervention	I:C1532338
(	O
Percutaneous	B:C1532338
coronary	I:C1532338
intervention	I:C1532338
)	O
is	O
effective	O
therapy	O
for	O
significant	O
atherosclerotic	O
coronary	I:C0010054
artery	I:C0010054
disease	I:C0010054
.	O

Percutaneous	O
coronary	I:C1532338
intervention	I:C1532338
(	O
Percutaneous	O
coronary	I:C1532338
intervention	I:C1532338
)	O
is	O
effective	O
therapy	B:C0087111
for	O
significant	O
atherosclerotic	O
coronary	I:C0010054
artery	I:C0010054
disease	I:C0010054
.	O

Percutaneous	O
coronary	I:C1532338
intervention	I:C1532338
(	O
Percutaneous	O
coronary	I:C1532338
intervention	I:C1532338
)	O
is	O
effective	O
therapy	O
for	O
significant	O
atherosclerotic	B:C0010054
coronary	I:C0010054
artery	I:C0010054
disease	I:C0010054
.	O

Despite	O
medical	O
and	O
technological	O
advances	O
in	O
Percutaneous	B:C1532338
coronary	I:C1532338
intervention	I:C1532338
,	O
periprocedural	O
myocardial	I:C3839342
infarction	I:C3839342
(	O
periprocedural	O
myocardial	I:C3839342
infarction	I:C3839342
)	O
remains	O
a	O
common	O
complication	O
.	O

Despite	O
medical	O
and	O
technological	O
advances	O
in	O
Percutaneous	O
coronary	I:C1532338
intervention	I:C1532338
,	O
periprocedural	B:C3839342
myocardial	I:C3839342
infarction	I:C3839342
(	O
periprocedural	O
myocardial	I:C3839342
infarction	I:C3839342
)	O
remains	O
a	O
common	O
complication	O
.	O

Despite	O
medical	O
and	O
technological	O
advances	O
in	O
Percutaneous	O
coronary	I:C1532338
intervention	I:C1532338
,	O
periprocedural	O
myocardial	I:C3839342
infarction	I:C3839342
(	O
periprocedural	B:C3839342
myocardial	I:C3839342
infarction	I:C3839342
)	O
remains	O
a	O
common	O
complication	O
.	O

Despite	O
medical	O
and	O
technological	O
advances	O
in	O
Percutaneous	O
coronary	I:C1532338
intervention	I:C1532338
,	O
periprocedural	O
myocardial	I:C3839342
infarction	I:C3839342
(	O
periprocedural	O
myocardial	I:C3839342
infarction	I:C3839342
)	O
remains	O
a	O
common	O
complication	B:C0009566
.	O

The	O
frequency	O
and	O
factors	O
associated	O
with	O
periprocedural	B:C3839342
myocardial	I:C3839342
infarction	I:C3839342
have	O
been	O
well	O
investigated	O
in	O
the	O
developed	O
world	I:C2700280
,	O
yet	O
there	O
is	O
a	O
paucity	O
of	O
data	O
from	O
the	O
developing	O
world	I:C2700280
,	O
especially	O
Sub	O
-Saharan	I:C0001738
Africa	I:C0001738
.	O

The	O
frequency	O
and	O
factors	O
associated	O
with	O
periprocedural	O
myocardial	I:C3839342
infarction	I:C3839342
have	O
been	O
well	O
investigated	O
in	O
the	O
developed	B:C2700280
world	I:C2700280
,	O
yet	O
there	O
is	O
a	O
paucity	O
of	O
data	O
from	O
the	O
developing	O
world	I:C2700280
,	O
especially	O
Sub	O
-Saharan	I:C0001738
Africa	I:C0001738
.	O

The	O
frequency	O
and	O
factors	O
associated	O
with	O
periprocedural	O
myocardial	I:C3839342
infarction	I:C3839342
have	O
been	O
well	O
investigated	O
in	O
the	O
developed	O
world	I:C2700280
,	O
yet	O
there	O
is	O
a	O
paucity	O
of	O
data	O
from	O
the	O
developing	B:C2700280
world	I:C2700280
,	O
especially	O
Sub	O
-Saharan	I:C0001738
Africa	I:C0001738
.	O

The	O
frequency	O
and	O
factors	O
associated	O
with	O
periprocedural	O
myocardial	I:C3839342
infarction	I:C3839342
have	O
been	O
well	O
investigated	O
in	O
the	O
developed	O
world	I:C2700280
,	O
yet	O
there	O
is	O
a	O
paucity	O
of	O
data	O
from	O
the	O
developing	O
world	I:C2700280
,	O
especially	O
Sub	B:C0001738
-Saharan	I:C0001738
Africa	I:C0001738
.	O

We	O
prospectively	O
enrolled	O
153	O
adult	O
patients	O
undergoing	O
Percutaneous	B:C1532338
coronary	I:C1532338
intervention	I:C1532338
at	O
the	O
Charlotte	O
Maxeke	I:C0019994
Johannesburg	I:C0019994
Academic	I:C0019994
Hospital	I:C0019994
from	O
the	O
1st	O
of	O
February	O
2014	O
to	O
31st	O
October	O
2014	O
.	O

We	O
prospectively	O
enrolled	O
153	O
adult	O
patients	O
undergoing	O
Percutaneous	O
coronary	I:C1532338
intervention	I:C1532338
at	O
the	O
Charlotte	B:C0019994
Maxeke	I:C0019994
Johannesburg	I:C0019994
Academic	I:C0019994
Hospital	I:C0019994
from	O
the	O
1st	O
of	O
February	O
2014	O
to	O
31st	O
October	O
2014	O
.	O

Periprocedural	B:C1141861
Creatinine	O
Kinase	I:C0523584
-	I:C0523584
MB	I:C0523584
and	O
hs	O
-	I:C0523952
Troponin	I:C0523952
I	I:C0523952
were	O
routinely	O
measured	O
before	O
Percutaneous	O
coronary	I:C1532338
intervention	I:C1532338
and	O
at	O
16	O
-	O
24h	O
post	O
-	O
procedure	O
.	O

Periprocedural	O
Creatinine	B:C0523584
Kinase	I:C0523584
-	I:C0523584
MB	I:C0523584
and	O
hs	O
-	I:C0523952
Troponin	I:C0523952
I	I:C0523952
were	O
routinely	O
measured	O
before	O
Percutaneous	O
coronary	I:C1532338
intervention	I:C1532338
and	O
at	O
16	O
-	O
24h	O
post	O
-	O
procedure	O
.	O

Periprocedural	O
Creatinine	O
Kinase	I:C0523584
-	I:C0523584
MB	I:C0523584
and	O
hs	B:C0523952
-	I:C0523952
Troponin	I:C0523952
I	I:C0523952
were	O
routinely	O
measured	O
before	O
Percutaneous	O
coronary	I:C1532338
intervention	I:C1532338
and	O
at	O
16	O
-	O
24h	O
post	O
-	O
procedure	O
.	O

Periprocedural	O
Creatinine	O
Kinase	I:C0523584
-	I:C0523584
MB	I:C0523584
and	O
hs	O
-	I:C0523952
Troponin	I:C0523952
I	I:C0523952
were	O
routinely	O
measured	O
before	O
Percutaneous	B:C1532338
coronary	I:C1532338
intervention	I:C1532338
and	O
at	O
16	O
-	O
24h	O
post	O
-	O
procedure	O
.	O

The	O
third	O
universal	O
definition	B:C1704788
of	O
myocardial	O
infarction	I:C0027051
was	O
used	O
to	O
define	O
a	O
periprocedural	O
myocardial	I:C3839342
infarction	I:C3839342
event	O
.	O

The	O
third	O
universal	O
definition	O
of	O
myocardial	B:C0027051
infarction	I:C0027051
was	O
used	O
to	O
define	O
a	O
periprocedural	O
myocardial	I:C3839342
infarction	I:C3839342
event	O
.	O

The	O
third	O
universal	O
definition	O
of	O
myocardial	O
infarction	I:C0027051
was	O
used	O
to	O
define	O
a	O
periprocedural	B:C3839342
myocardial	I:C3839342
infarction	I:C3839342
event	O
.	O

152	O
participants	B:C0679646
met	O
the	O
inclusion	O
criteria	O
and	O
were	O
analysed	O
for	O
periprocedural	O
myocardial	I:C3839342
infarction	I:C3839342
.	O

152	O
participants	O
met	O
the	O
inclusion	O
criteria	O
and	O
were	O
analysed	B:C0936012
for	O
periprocedural	O
myocardial	I:C3839342
infarction	I:C3839342
.	O

152	O
participants	O
met	O
the	O
inclusion	O
criteria	O
and	O
were	O
analysed	O
for	O
periprocedural	B:C3839342
myocardial	I:C3839342
infarction	I:C3839342
.	O

70.4	O
%	O
participants	B:C0679646
were	O
male	O
.	O

70.4	O
%	O
participants	O
were	O
male	B:C0025266
.	O

Sixteen	O
(	O
10.5	O
%	O
)	O
participants	B:C0679646
fulfilled	O
the	O
criteria	O
for	O
periprocedural	O
myocardial	I:C3839342
infarction	I:C3839342
.	O

Sixteen	O
(	O
10.5	O
%	O
)	O
participants	O
fulfilled	O
the	O
criteria	O
for	O
periprocedural	B:C3839342
myocardial	I:C3839342
infarction	I:C3839342
.	O

Side	O
branch	O
pinching	B:C0418416
with	O
preserved	O
TIMI	O
III	I:C3272287
flow	I:C3272287
was	O
noted	O
in	O
62.5	O
%	O
of	O
periprocedural	O
myocardial	I:C3839342
infarction	I:C3839342
cases	O
.	O

Side	O
branch	O
pinching	O
with	O
preserved	O
TIMI	B:C3272287
III	I:C3272287
flow	I:C3272287
was	O
noted	O
in	O
62.5	O
%	O
of	O
periprocedural	O
myocardial	I:C3839342
infarction	I:C3839342
cases	O
.	O

Side	O
branch	O
pinching	O
with	O
preserved	O
TIMI	O
III	I:C3272287
flow	I:C3272287
was	O
noted	O
in	O
62.5	O
%	O
of	O
periprocedural	B:C3839342
myocardial	I:C3839342
infarction	I:C3839342
cases	O
.	O

Duration	O
of	O
procedure	O
(	O
P=0.007	O
)	O
,	O
right	B:C0226042
coronary	I:C0226042
artery	I:C0226042
intervention	O
(	O
p=0.042	O
)	O
and	O
total	O
stent	O
length	O
(	O
p=0.045	O
)	O
were	O
independently	O
associated	O
with	O
periprocedural	O
myocardial	I:C3839342
infarction	I:C3839342
.	O

Duration	O
of	O
procedure	O
(	O
P=0.007	O
)	O
,	O
right	O
coronary	I:C0226042
artery	I:C0226042
intervention	B:C0184661
(	O
p=0.042	O
)	O
and	O
total	O
stent	O
length	O
(	O
p=0.045	O
)	O
were	O
independently	O
associated	O
with	O
periprocedural	O
myocardial	I:C3839342
infarction	I:C3839342
.	O

Duration	O
of	O
procedure	O
(	O
P=0.007	O
)	O
,	O
right	O
coronary	I:C0226042
artery	I:C0226042
intervention	O
(	O
p=0.042	O
)	O
and	O
total	O
stent	O
length	O
(	O
p=0.045	O
)	O
were	O
independently	O
associated	O
with	O
periprocedural	B:C3839342
myocardial	I:C3839342
infarction	I:C3839342
.	O

periprocedural	B:C3839342
myocardial	I:C3839342
infarction	I:C3839342
occurred	O
in	O
10.5	O
%	O
of	O
cases	O
undergoing	O
Percutaneous	O
coronary	I:C1532338
intervention	I:C1532338
.	O

periprocedural	O
myocardial	I:C3839342
infarction	I:C3839342
occurred	O
in	O
10.5	O
%	O
of	O
cases	O
undergoing	O
Percutaneous	B:C1532338
coronary	I:C1532338
intervention	I:C1532338
.	O

This	O
is	O
consistent	O
with	O
the	O
prevalence	O
of	O
periprocedural	B:C3839342
myocardial	I:C3839342
infarction	I:C3839342
internationally	O
.	O

Larger	O
multicentre	B:C1096776
studies	I:C1096776
are	O
required	O
in	O
our	O
demographic	O
region	O
to	O
further	O
define	O
relevant	O
predictors	O
and	O
outcomes	O
associated	O
with	O
periprocedural	O
myocardial	I:C3839342
infarction	I:C3839342
.	O

Larger	O
multicentre	O
studies	I:C1096776
are	O
required	O
in	O
our	O
demographic	O
region	O
to	O
further	O
define	O
relevant	O
predictors	O
and	O
outcomes	O
associated	O
with	O
periprocedural	B:C3839342
myocardial	I:C3839342
infarction	I:C3839342
.	O

